6-aryl naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation
US5952342A · kind A · utility
15Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 1998 |
| Grant date | Sep 14, 1999 |
| Priority date | — |
| Expiry date | Mar 18, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
6-Aryl naphthyridines are inhibitors of protein tyrosine kinase, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating atherosclerosis, restenosis, psoriasis, as well as bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.